A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
NCT07746687 · Asthma
The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).
PhasePhase 2
TypeInterventional
Age18 Years – 85 Years
WhereWestminster, California, United States + 18 more
SponsorJanssen Research & Development, LLC
▾Tap for detailsClick for full details — eligibility, all locations, contacts
19 sitesApply